Outer membrane protein LipL21 as a potential candidate against Leptospira interrogans: An in silico prediction

Anita Kumari1, Devinder Toor

  • 1Amity Institute of Virology and Immunology, Amity University, Noida, Uttar Pradesh, India.

PubMed

Insights

Researchers identified LipL21 as a highly antigenic outer membrane protein for Leptospira interrogans. This conserved protein shows promise as a vaccine candidate for effective leptospirosis prevention.

Area of Science:

  • Microbiology
  • Immunology
  • Bioinformatics

Background:

  • Leptospirosis, caused by Leptospira interrogans, is a significant zoonotic disease with variable clinical presentations.
  • Current vaccines offer limited duration of immunity and serovar-specific protection, necessitating novel approaches.

Purpose of the Study:

  • To identify a conserved and immunogenic outer membrane protein (OMP) of Leptospira interrogans for potential vaccine development.
  • To evaluate OMPs including OmpL1, LipL21, LipL32, and LipL41 using computational methods.

Main Methods:

  • Computational analysis including VaxiJen, BCPred, and MHCPred were employed to assess antigenicity and epitope prediction.
  • Protein conservation analysis using Clustal Omega and confirmational analysis of B-cell epitopes were performed.

Main Results:

  • LipL21 demonstrated the highest antigenicity score (0.7848) via VaxiJen analysis.
  • LipL21 possesses both B-cell and T-cell epitopes, indicating immunogenicity, and is conserved in pathogenic but absent in nonpathogenic Leptospira strains.

Conclusions:

  • LipL21 is predicted as a promising vaccine candidate due to its high antigenicity, immunogenicity, and conservation across pathogenic Leptospira serovars.
  • This study highlights the potential of LipL21 for developing broadly protective vaccines against leptospirosis.